Alzamend Neuro Inc expected to post a loss of 67 cents a share - Earnings Preview
Alzamend Neuro Inc <ALZN.OQ> expected to post a loss of 67 cents a share - Earnings Preview
Alzamend Neuro Inc ALZN.OQ ALZN.O is expected to show no change in quarterly revenue when it reports results on July 20 (estimated) for the period ending April 30 2026
LSEG's mean analyst estimate for Alzamend Neuro Inc is for a loss of 67 cents per share.
The one available analyst rating on the shares is "buy".
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Alzamend Neuro Inc is $25.00, about 1,949.2% above its last closing price of $1.22
This summary was machine generated July 17 at 20:20 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
Recent news on Alzamend Neuro
See all newsAlzamend Neuro Inc reports results for the quarter ended April 30 - Earnings Summary
Alzamend Neuro Inc expected to post a loss of 23 cents a share - Earnings Preview
Alzamend Neuro Inc expected to post a loss of 56 cents a share - Earnings Preview
Alzamend Neuro Inc reports results for the quarter ended April 30 - Earnings Summary
Alzamend Neuro Inc expected to post a loss of 67 cents a share - Earnings Preview